---
title: "NKF's subsidiary product Hydrazine Hydrate Injection has been approved by the U.S. FDA"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243053774.md"
description: "NKF's subsidiary, Jianjin Pharmaceutical, recently received approval from the U.S. FDA to launch Hydralazine Hydrochloride Injection (20mg/mL, single dose), which is suitable for patients with severe primary hypertension who cannot take oral medication or require emergency blood pressure reduction. The product is expected to be launched in the U.S. soon and is anticipated to have a positive impact on the company's performance"
datetime: "2025-06-04T07:58:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243053774.md)
  - [en](https://longbridge.com/en/news/243053774.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243053774.md)
generator: "portal-rs"
---

# NKF's subsidiary product Hydrazine Hydrate Injection has been approved by the U.S. FDA

According to the Zhitong Finance APP, NKF (603707.SH) announced that its subsidiary, Jianjin Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianjin Pharmaceutical"), recently received an ANDA approval notification (ANDA No.: 217501) from the U.S. Food and Drug Administration (hereinafter referred to as "U.S. FDA") for Hydralazine Hydrochloride Injection, 20mg/mL, single dose.

This drug is indicated for use in patients with severe primary hypertension when oral administration is not possible or when urgent blood pressure reduction is needed. The newly approved product will be scheduled for sale in the U.S. soon, which is expected to have a positive impact on the company's operating performance

### Related Stocks

- [603707.CN](https://longbridge.com/en/quote/603707.CN.md)

## Related News & Research

- [Tianjin Development FY26 H1 profit attributable to owners falls 5.58% to HK$ 325.22 million; revenue slips 3.53% to HK$ 1.66 billion](https://longbridge.com/en/news/297300410.md)
- [11:34 ETHUMAIN and Applied Intuition Announce Strategic Collaboration to Deploy Physical AI Across Saudi Arabia, Starting with Autonomous Trucking](https://longbridge.com/en/news/297540098.md)
- [Biocytogen Pharmaceuticals announces extraordinary general meeting](https://longbridge.com/en/news/297148979.md)
- [ICTSI unit Contecon Manzanillo wins approval to handle 15.5-meter-draft vessels](https://longbridge.com/en/news/297477639.md)
- [Festi hf.: Transactions in relation to a share repurchase programme - week 35](https://longbridge.com/en/news/297484499.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**